Matches in Wikidata for { <http://www.wikidata.org/entity/Q86323999> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q86323999 description "artículu científicu espublizáu en setiembre de 2015" @default.
- Q86323999 description "im September 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86323999 description "scientific article published on 29 September 2015" @default.
- Q86323999 description "wetenschappelijk artikel" @default.
- Q86323999 description "наукова стаття, опублікована у вересні 2015" @default.
- Q86323999 name "Correction: Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q86323999 name "Correction: Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q86323999 type Item @default.
- Q86323999 label "Correction: Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q86323999 label "Correction: Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q86323999 prefLabel "Correction: Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q86323999 prefLabel "Correction: Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q86323999 P1433 Q86323999-C4873343-9319-4899-99F6-2DB1385037E9 @default.
- Q86323999 P1476 Q86323999-9B19677C-57EC-4474-A565-9B0FB01F4AC3 @default.
- Q86323999 P304 Q86323999-9ECCF6EE-D7B3-4ED8-B905-12A847387179 @default.
- Q86323999 P31 Q86323999-D43291ED-1F04-4E7F-B4B5-48821EF3151A @default.
- Q86323999 P356 Q86323999-5807B91A-F583-4284-92E3-0AE09A4D2DAF @default.
- Q86323999 P433 Q86323999-5B458A6B-9830-4512-84DB-062E7E938507 @default.
- Q86323999 P478 Q86323999-2B2204B5-E447-45AB-AFA2-393B476D2DB2 @default.
- Q86323999 P577 Q86323999-AF8DAFF8-B14F-4A06-963E-5A7745E9B4BD @default.
- Q86323999 P698 Q86323999-442D721F-5B40-42BF-A1F3-8FAB9CD14E54 @default.
- Q86323999 P356 1541-7786.MCR-15-0277 @default.
- Q86323999 P698 26420623 @default.
- Q86323999 P1433 Q2751014 @default.
- Q86323999 P1476 "Correction: Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma" @default.
- Q86323999 P304 "1441" @default.
- Q86323999 P31 Q13442814 @default.
- Q86323999 P356 "10.1158/1541-7786.MCR-15-0277" @default.
- Q86323999 P433 "10" @default.
- Q86323999 P478 "13" @default.
- Q86323999 P577 "2015-09-29T00:00:00Z" @default.
- Q86323999 P698 "26420623" @default.